Paxlovid rebound happens, though why and to whom are still a mystery
Covid has settled into a persistent pattern — and remains damaging. It may not change anytime soon
Patients seeking novel weight loss drugs find a ‘wild west’ of online prescribers
With monkeypox vaccine in high demand, NIH to test approaches to stretch supplies
Addressing social drivers of health is a big opportunity for tech entrepreneurs
The need for speed and safety: A primer on the FDA’s drug approval pathways
Continuous glucose monitoring: how it’s advancing diabetes care
The ‘shroom boom’: The meteoric rise of the psychedelic medicine industry
